» Authors » Florian Schoberl

Florian Schoberl

Explore the profile of Florian Schoberl including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 534
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiesenfarth M, Forouhideh-Wiesenfarth Y, Elmas Z, Parlak O, Weiland U, Herrmann C, et al.
J Neurol . 2025 Mar; 272(4):259. PMID: 40056187
No abstract available.
2.
Volter F, Eckenweber S, Scheifele M, Eckenweber F, Hirsch F, Franzmeier N, et al.
Eur J Nucl Med Mol Imaging . 2025 Feb; PMID: 40019578
Purpose: Clinical staging in individuals with Alzheimer's disease (AD) typically relies on neuropsychological testing. Recognizing the imperative for an objective measure of clinical AD staging, regional perfusion in early-phase β-amyloid-PET...
3.
Schmitt C, Muller K, Tiedt S, Kramer N, Manger I, Knauss S, et al.
Int J Cancer . 2025 Jan; PMID: 39831665
Neurologic immune-related adverse events (nirAEs) represent rare, yet severe side effects associated with immune checkpoint inhibitor (ICI) therapy. Given the absence of established diagnostic biomarkers for nirAEs, we aimed to...
4.
Grill E, Zwergal A, Sauer D, Saur D, Klingbeil J, Fricke C, et al.
Front Neurol . 2024 Dec; 15:1452150. PMID: 39726764
Introduction: Modifiable risk factors play an important role in preventing dementia and reducing its progression. Regular physical activity already in midlife, which relies on intact multisensory balance control, can help...
5.
Thunstedt C, Aydemir D, Conrad J, Wlasich E, Loosli S, Schoberl F, et al.
Brain Sci . 2024 Sep; 14(9). PMID: 39335373
Background: Idiopathic intracranial hypertension (IIH) is typically characterized by headaches and vision loss. However, neurocognitive deficits are also described. Our study aimed to test the influence of therapeutic lumbar puncture...
6.
Dilcher R, Wall S, Gross M, Katzdobler S, Wagemann O, Palleis C, et al.
Alzheimers Dement . 2024 Sep; 20(10):6896-6909. PMID: 39263969
Introduction: Recent advances in biomarker research have improved the diagnosis and monitoring of Alzheimer's disease (AD), but in vivo biomarker-based workflows to assess 4R-tauopathy (4RT) patients are currently missing. We...
7.
Wiesenfarth M, Forouhideh-Wiesenfarth Y, Elmas Z, Parlak O, Weiland U, Herrmann C, et al.
J Neurol . 2024 Aug; 271(10):6667-6679. PMID: 39141064
Pathogenic variants in the Cu/Zn superoxide dismutase (SOD1) gene can be detected in approximately 2% of sporadic and 11% of familial amyotrophic lateral sclerosis (ALS) patients in Europe. We analyzed...
8.
Muller K, Schmidbauer M, Schonecker S, Kamm K, Pelz J, Holzapfel K, et al.
J Neurol . 2024 Jul; 271(9):6255-6263. PMID: 39085618
Background: Several single-center studies proposed utility of vagus nerve (VN) ultrasound for detecting disease severity, autonomic dysfunction, and bulbar phenotype in amyotrophic lateral sclerosis (ALS). However, the resulting body of...
9.
Linse K, Weber C, Reilich P, Schoberl F, Boentert M, Petri S, et al.
Neurol Res Pract . 2024 Jul; 6(1):34. PMID: 38961496
Introduction: Amyotrophic lateral sclerosis (ALS) is an inevitably fatal condition that leads to a progressive loss of physical functioning, which results in a high psychosocial burden and organizational challenges related...
10.
Schaub A, Erdmann H, Scholz V, Timmer M, Cordts I, GuNTHER R, et al.
J Neurol . 2024 Jun; 271(9):5804-5812. PMID: 38916676
Biallelic pathogenic repeat expansions in RFC1 were recently identified as molecular origin of cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) as well as of one of the most common causes...